切换至 "中华医学电子期刊资源库"

中华细胞与干细胞杂志(电子版) ›› 2022, Vol. 12 ›› Issue (05) : 309 -313. doi: 10.3877/cma.j.issn.2095-1221.2022.05.008

综述

间充质干细胞源性外泌体对子痫前期滋养层细胞生物学行为影响的研究进展
何豆豆1, 孙晓彤2,(), 曲涛3, 李忠媛1, 杨雪萍1   
  1. 1. 730000 兰州,甘肃中医药大学第一临床医学院
    2. 730000 兰州,甘肃省人民医院产科
    3. 730000 兰州,甘肃省人民医院生物转化所实验室
  • 收稿日期:2022-09-09 出版日期:2022-10-01
  • 通信作者: 孙晓彤
  • 基金资助:
    国家自然科学基金地区科学基金项目(32060172); 甘肃省科技计划项目(创新基地和人才计划)(21JR7RA608); 甘肃省青年科技基金(20JR10RA416)

Research progress on the effects of mesenchymal stem cell-derived exosomes on the biological behaviour of preeclamptic trophoblast cells

Doudou He1, Xiaotong Sun2,(), Tao Qu3, Zhongyuan Li1, Xueping Yang1   

  1. 1. The First Clinical Medical College of Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China
  • Received:2022-09-09 Published:2022-10-01
  • Corresponding author: Xiaotong Sun
引用本文:

何豆豆, 孙晓彤, 曲涛, 李忠媛, 杨雪萍. 间充质干细胞源性外泌体对子痫前期滋养层细胞生物学行为影响的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2022, 12(05): 309-313.

Doudou He, Xiaotong Sun, Tao Qu, Zhongyuan Li, Xueping Yang. Research progress on the effects of mesenchymal stem cell-derived exosomes on the biological behaviour of preeclamptic trophoblast cells[J/OL]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2022, 12(05): 309-313.

子痫前期(PE)是一种严重影响孕产妇围产结局的妊娠中晚期特有并发症,其具体发病机制至今仍不明确,且目前尚无有效的治疗手段。外泌体作为间充质干细胞(MSCs)旁分泌作用的主要方式,在细胞间的信息交流中扮演重要角色,同时发现外泌体内携带的如微小RNA (miRNA)等小分子物质参与靶向细胞的多种生理病理过程。近年来相关研究发现不同来源MSCs的外泌体能够通过改善滋养层细胞功能为治疗PE患者提供潜在的治疗手段。随着研究的不断深入,不同来源MSCs及其外泌体将在PE患者的靶向药物治疗方面发挥巨大的潜力,可降低PE患者不良围产结局发生率及保障围产期母婴安全。本文将通过阐述不同来源MSCs的基本特点,分析其外泌体在PE滋养层细胞中的治疗作用,为临床治疗PE患者提供新的视角和思路。

Preeclampsia (PE) is a unique complication in the second and third trimesters of pregnancy that seriously affects the perinatal outcome of pregnant women. Its specific pathogenesis is still unclear, and there is currently no effective treatment. As the main mode of the paracrine effect of mesenchymal stem cells (MSCs) , exosomes play an essential role in the communication of information between cells. Exosomes that carry small molecules such as micorRNAs have also been found to be involved in a physiological and pathological process. In recent years, related studies have found that exosomes from different sources of MSCs can provide a potential therapeutic method for treating PE by improving the function of trophoblast cells. It is believed that with the continuous deepening of research, MSCs from different sources and their exosomes will play amassive potential in the targeted drug therapy of patients with PE, reducing the incidence of adverse perinatal outcomes and ensuring the safety of mothers and babies. This article will describe the essential characteristics of MSCs from different sources and analyze the therapeutic effect of exosomes in PE trophoblast cells to provide new perspectives and ideas for the clinical treatment of PE.

1
Aneman I, Pienaar D, Suvakov S, et al. Mechanisms of key innate immune cells in early-and late-onset preeclampsia[J]. Front Immunol, 2020, 11:1864. doi:10.3389/fimmu.2020.01864.
2
Suvakov S, Richards C, Nikolic V, et al. Emerging therapeutic totential of mesenchymal stem/stromal cells in preeclampsia[J]. Curr Hypertens Rep, 2020, 22(5):37. doi: 10.1007/s11906-020-1034-8.
3
史昊然, 赵茵. 间充质干细胞来源的外泌体在子痫前期中的实验研究进展[J]. 中华围产医学杂志, 2022, 25(2):154-157.
4
白佳萌,刘光伟,谢露,等.间充质干细胞及其外泌体在肝再生领域的应用[J].中国组织工程研究, 2022, 26(19):3071-3077.
5
Grimes S, Bombay K, Lanes A, et al. Potential biological therapies for severe preeclampsia: a systematic review and meta-analysis[J]. BMC Pregnancy Childbirth, 2019, 19(1):163. doi: 10.1186/s12884-019-2268-9.
6
彭绪峰, 陈方. 间充质干细胞外泌体的免疫调节功能及其在自身免疫炎性疾病中的应用[J/CD]. 中华细胞与干细胞杂志(电子版), 2020, 10(4):246-250.
7
沈志明, 袁磊, 卢毅, 等. 间充质干细胞外泌体在创伤修复再生中作用的研究进展[J]. 中华创伤杂志, 2022, 38(2):182-186.
8
付长秀, 孙建伟, 张芸, 等. 间充质干细胞外泌体在眼部疾病中的研究进展[J].中国免疫学杂志, 2021, 37(18):2295-2299.
9
张雨诗, 曹莉旻, 文婷婷, 等. 间充质干细胞外泌体对肺部疾病的治疗及研究进展[J]. 国际呼吸杂志, 2022, 42(8):630-635.
10
Gupta PK, Das AK, Chullikana A, et al. Mesenchymal stem cells for cartilage repair in osteoarthritis[J]. Stem Cell Res Ther, 2012, 3(4):25.doi:10.1186/scrt116.
11
Barry F. MSC therapy for osteoarthritis: an unfinished story[J]. J Orthop Res, 2019, 37(6):1229-1235.
12
Volarevic V, Markovic BS, Gazdic M, et al. Ethical and safety issues of stem cell-based therapy[J]. Int J Med Sci, 2018, 15(1):36-45.
13
Ferreira JR, Teixeira GQ, Santos SG, et al. Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning[J]. Front Immunol, 2018, 9:2837. doi: 10.3389/fimmu.2018.02837.
14
Harrell CR, Fellabaum C, Jovicic N, et al. Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome[J]. Cells, 2019, 8(5):467. doi: 10.3390/cells8050467.
15
Li JJ, Hosseini-Beheshti E, Grau GE, et al. Stem cell-derived extracellular vesicles for treating joint injury and osteoarthritis[J]. Nanomaterials(Basel), 2019, 9(2):261. doi: 10.3390/nano9020261.
16
Caplan H, Olson SD, Kumar A, et al. Mesenchymal stromal cell therapeutic delivery: translational challenges to clinical application[J]. Front Immunol, 2019, 10:1645. doi: 10.3389/fimmu.2019.01645.
17
Zhu X, Badawi M, Pomeroy S, et al. Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells[J]. J Extracell Vesicles, 2017, 6(1):1324730. doi:10.1080/20013078.2017.1324730.
18
Konečná B, Tóthová Ľ, Repiská G. Exosomes-associated DNA-new marker in pregnancy complications?[J]. Int J Mol Sci, 2019, 20(12):2890. doi:10.3390/ijms20122890.
19
van Niel G, D'Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles[J]. Nat Rev Mol Cell Biol, 2018, 19(4):213-228.
20
Pan Q, Wang Y, Lan Q, et al. Exosomes derived from mesenchymal stem cells ameliorate hypoxia/reoxygenation-injured ECs via transferring microRNA-126[J]. Stem Cells Int, 2019, 2019:2831756.doi:10.1155/2019/2831756.
21
Chen F, Chen X, Cai W, et al. Mesenchymal stem cell-derived exosomal long noncoding RNA MALAT1-201 regulated the proliferation, apoptosis and migration of trophoblast cells via targeting miR-141[J]. Ann Clin Lab Sci, 2022, 52(5):741-752.
22
Chen Y, Ding H, Wei M, et al. MSC-secreted exosomal H19 promotes trophoblast cell invasion and migration by downregulating let-7b and upregulating FOXO1[J]. Mol Ther Nucleic Acids, 2020, 19:1237-1249.
23
赵馨扬,谭季春.不同来源的间充质干细胞及其外泌体治疗早发性卵巢功能不全的作用及机制研究进展[J]. 中华生殖与避孕杂志, 2021, 41(7):661-667.
24
Ferreira LMR, Meissner TB, Tilburgs T, et al. HLA-G: at the interface of maternal-fetal tolerance[J]. Trends Immunol, 2017, 38(4):272-286.
25
Alshabibi MA, Khatlani T, Abomaray FM, et al. Human decidua basalis mesenchymal stem/stromal cells protect endothelial cell functions from oxidative stress induced by hydrogen peroxide and monocytes[J]. Stem Cell Res Ther, 2018, 9(1):275. doi: 10.1186/s13287-018-1021-z.
26
Kusuma GD, Abumaree MH, Perkins AV, et al. Reduced aldehyde dehydrogenase expression in preeclamptic decidual mesenchymal stem/stromal cells is restored by aldehyde dehydrogenase agonists[J]. Sci Rep, 2017, 7:42397. doi: 10.1038/srep42397.
27
Kamali Simsek N, Benian A, Sevgin K, et al. Microrna analysis of human decidua mesenchymal stromal cells from preeclampsia patients[J]. Placenta, 2021, 115:12-19.
28
Zhao G, Zhou X, Chen S, et al. Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with preeclampsia[J]. J Biomed Sci, 2014, 21(1):81.doi: 10.1186/s12929-014-0081-3.
29
Xin G, Du J, Liu MY, et al. Upregulation of MiR-29b contributes to mesenchymal stem cell dysfunction in patients with severe pre-eclampsia[J]. Int J Clin Exp Pathol, 2017, 10(10):10243-10251.
30
Lei GQ, Wu ZY, Jiang WB, et al. Effect of CXCL12/CXCR4 on migration of decidua-derived mesenchymal stem cells from pregnancies with preeclampsia[J]. Am J Reprod Immunol, 2019, 82(5):e13180. doi: 10.1111/aji.13180.
31
Basmaeil YS, Algudiri D, Alenzi R, et al. HMOX1 is partly responsible for phenotypic and functional abnormalities in mesenchymal stem cells/stromal cells from placenta of preeclampsia (PE) patients[J]. Stem Cell Res Ther, 2020, 11(1):30. doi: 10.1186/s13287-020-1557-6.
32
Khatlani T, Algudiri D, Alenzi R, et al. Preconditioning by hydrogen peroxide enhances multiple properties of human decidua basalis mesenchymal stem/multipotent stromal cells[J]. Stem Cells Int, 2018, 2018:6480793. doi: 10.1155/2018/6480793.
33
Wu D, Liu Y, Liu X, et al. Heme oxygenase-1 gene modified human placental mesenchymal stem cells promote placental angiogenesis and spiral artery remodeling by improving the balance of angiogenic factors in vitro[J]. Placenta, 2020, 99:70-77.
34
Zheng S, Shi A, Hill S, et al. Decidual mesenchymal stem/stromal cell-derived extracellular vesicles ameliorate endothelial cell proliferation, inflammation, and oxidative stress in a cell culture model of preeclampsia[J]. Pregnancy Hypertens, 2020, 22:37-46.
35
Ridder A, Giorgione V, Khalil A, et al. Preeclampsia: the relationship between uterine artery blood flow and trophoblast function[J]. Int J Mol Sci, 2019, 20(13):3263.
36
Kannaiyan J, Muthukutty P, Iqbal MDT, et al. Villous chorion: a potential source for pluripotent-like stromal cells[J]. J Nat Sci Biol Med, 2017, 8(2):221-228.
37
Uder C, Brückner S, Winkler S, et al. Mammalian MSC from selected species: features and applications[J]. Cytometry A, 2018, 93(1):32-49.
38
Chu Y, Zhu C, Yue C, et al. Chorionic villus-derived mesenchymal stem cell-mediated autophagy promotes the proliferation and invasiveness of trophoblasts under hypoxia by activating the JAK2/STAT3 signalling pathway[J]. Cell Biosci, 2021, 11(1):182. doi: 10.1186/s13578-021-00681-7.
39
Abumaree MH, Alshehri NA, Almotery A, et al. Preconditioning human natural killer cells with chorionic villous mesenchymal stem cells stimulates their expression of inflammatory and anti-tumor molecules[J]. Stem Cell Res Ther, 2019, 10(1):50. doi: 10.1186/s13287-019-1153-9.
40
Li Y, Wang C, Xi HM, et al. Chorionic villus-derived mesenchymal stem cells induce E3 ligase TRIM72 expression and regulate cell behaviors through ubiquitination of p53 in trophoblasts[J]. FASEB J, 2021, 35(12):e22005. doi: 10.1096/fj.202100801R.
41
Umezawa A, Hasegawa A, Inoue M, et al. Amnion-derived cells as a reliable resource for next-generation regenerative medicine[J]. Placenta, 2019, 84:50-56.
42
薛玲玲,陈锦阳,庄盼,等.人羊膜上皮细胞和人羊膜间充质干细胞的研究进展[J/CD]. 中华细胞与干细胞杂志(电子版), 2021, 11(3): 184-188.
43
Mac Donald ES, Barrett JG. The potential of mesenchymal stem cells to treat systemic inflammation in horses[J]. Front Vet Sci, 2020, 6:507. doi:10.3389/fvets.2019.00507.
44
Chu Y, Chen W, Peng W, et al. Amnion-derived mesenchymal stem cell exosomes-mediated autophagy promotes the survival of trophoblasts under hypoxia through mTOR pathway by the downregulation of EZH2[J]. Front Cell Dev Biol, 2020, 8:545852. doi: 10.3389/fcell.2020.545852.
45
Surico D, Bordino V, Cantaluppi V, et al. Preeclampsia and intrauterine growth restriction: Role of human umbilical cord mesenchymal stem cells-trophoblast cross-talk[J]. PLoS One, 2019, 14(6):e0218437.doi: 10.1371/journal.pone.0218437.
46
Liu H, Wang F, Zhang Y, et al. Exosomal microRNA-139-5p from mesenchymal stem cells accelerates trophoblast cell invasion and migration by motivation of the ERK/MMP-2 pathway via downregulation of protein tyrosine phosphatase[J]. J Obstet Gynaecol Res, 2020, 46(12):2561-2572.
47
Wang D, Na Q, Song GY, et al. Human umbilical cord mesenchymal stem cell-derived exosome-mediated transfer of microRNA-133b boosts trophoblast cell proliferation, migration and invasion in preeclampsia by restricting SGK1[J]. Cell Cycle, 2020, 19(15):1869-1883.
48
Huang Q, Gong M, Tan T, et al. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-18b-3p inhibits the occurrence of preeclampsia by targeting LEP[J]. Nanoscale Res Lett, 2021, 16(1):27. doi: 10.1186/s11671-021-03475-5.
49
Xiong ZH, Wei J, Lu MQ, et al. Protective effect of human umbilical cord mesenchymal stem cell exosomes on preserving the morphology and angiogenesis of placenta in rats with preeclampsia[J]. Biomed Pharmacother, 2018, 105:1240-1247.
50
Yang Z, Shan N, Deng Q, et al. Extracellular vesicle-derived microRNA-18b ameliorates preeclampsia by enhancing trophoblast proliferation and migration via Notch2/TIM3/mTORC1 axis[J]. J Cell Mol Med, 2021, 25(10):4583-4595.
51
Cui J, Chen X, Lin S, et al. MiR-101-containing extracellular vesicles bind to BRD4 and enhance proliferation and migration of trophoblasts in preeclampsiaJ]. Stem Cell Res Ther, 2020, 11(1):231.doi: 10.1186/s13287-020-01720-9.
52
Motawi TMK, Sabry D, Maurice NW, et al. Role of mesenchymal stem cells exosomes derived microRNAs; miR-136, miR-494 and miR-495 in pre-eclampsia diagnosis and evaluation[J]. Arch Biochem Biophys, 2018, 659:13-21.
53
Taglauer ES, Fernandez-Gonzalez A, Willis GR, et al. Antenatal mesenchymal stromal cell extracellular vesicle therapy prevents preeclamptic lung injury in mice[J]. Am J Respir Cell Mol Biol, 2022, 66(1):86-95.
54
Yang C, Lim W, Park J, et al. Anti-inflammatory effects of mesenchymal stem cell-derived exosomal microRNA-146a-5p and microRNA-548e-5p on human trophoblast cells[J]. Mol Hum Reprod, 2019, 25(11):755-771.
55
Peñailillo R, Acuña-Gallardo S, García F, et al. Mesenchymal stem cells-induced trophoblast invasion is reduced in patients with a previous history of preeclampsia[J]. Int J Mol Sci, 2022, 23(16):9071. doi: 10.3390/ijms23169071.
[1] 刘政宏, 袁春銮. 乳腺癌患者血清外泌体中长链非编码RNA BC200的表达及临床意义[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(04): 212-216.
[2] 费扬, 赵晗希, 孙丽琴, 楼琴华, 胡骏程. 银杏叶提取物对糖尿病肾病患者的疗效及其对尿液外泌体miR-342-3p的干预研究[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(03): 219-224.
[3] 刘昌玲, 张金丽, 张志, 李孝建, 汤文彬, 胡逸萍, 陈宾, 谢晓娜. 负载人脂肪干细胞外泌体的甲基丙烯酰化明胶水凝胶对人皮肤成纤维细胞增殖和迁移的影响[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 517-525.
[4] 宋勤琴, 李双汝, 李林, 杜鹃, 刘继松. 间充质干细胞源性外泌体在改善病理性瘢痕中作用的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 550-553.
[5] 曹胜军, 李全, 符雪, 邵天喜, 周延华. 人脂肪间充质干细胞多层膜片对促进裸鼠皮肤缺损愈合的效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 341-347.
[6] 蔡定钦, 孙建国, 陈旭. 外泌体非编码RNAs与肺癌放射治疗的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 655-658.
[7] 傅红兴, 王植楷, 谢贵林, 蔡娟娟, 杨威, 严盛. 间充质干细胞促进胰岛移植效果的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 351-360.
[8] 王大伟, 陆雅斐, 皇甫少华, 陈玉婷, 陈澳, 江滨. 间充质干细胞通过调控免疫机制促进创面愈合的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 361-366.
[9] 袁园园, 岳乐淇, 张华兴, 武艳, 李全海. 间充质干细胞在呼吸系统疾病模型中肺组织分布及治疗机制的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 374-381.
[10] 王俊楠, 刘晔, 李若涵, 叶青松. 间充质干细胞调控肠脑轴治疗神经系统疾病的潜力[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 313-319.
[11] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[12] 张蔚林, 王哲学, 白峻阁, 黄忠诚, 肖志刚. 利用TCGA数据库构建基于miRNA的结直肠癌列线图预后模型[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 381-388.
[13] 季鹏程, 鄂一民, 陆晨, 喻春钊. 循环外泌体相关生物标志物在结直肠癌诊断中的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 265-273.
[14] 李京, 牛博, 刘晓蓓, 魏新雪, 黄荣. circ-SESN2 沉默靶向调控miRNA-23a-5p/ULK1 在神经细胞氧化应激损伤中的作用机制研究[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 263-272.
[15] 汪鹏飞, 程莹莹, 赵海康. 骨髓间充质干细胞改善神经病理性疼痛的机制探讨[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 230-234.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?